Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients.

导出 OA

翻译打印收藏纠错

第一作者： Anna,Nurmi

第一单位： Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

作者： Anna,Nurmi ^[1] ; Taru A,Muranen ^[1] ; Liisa M,Pelttari ^[1] ; Johanna I,Kiiski ^[1] ; Tuomas,Heikkinen ^[1] ; Sini,Lehto ^[1] ; Anne,Kallioniemi ^[2] ; Johanna,Schleutker ^[3] ; Ralf,Bützow ^[1] ; Carl,Blomqvist ^[4] ; Kristiina,Aittomäki ^[5] ; Heli,Nevanlinna ^[6]

作者单位： Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. ^[1] BioMediTech Institute and Faculty of Medicine and Health Technology, Tampere University and Fimlab Laboratories, Tampere, Finland. ^[2] Institute of Biomedicine, University of Turku, and Department of Medical Genetics, Genomics, Laboratory Division, Turku University Hospital, Turku, Finland. ^[3] Department of Pathology and University of Helsinki and Helsinki University Hospital, Helsinki, Finland. ^[4] Department of Oncology and University of Helsinki and Helsinki University Hospital, Helsinki, Finland. ^[5] Department of Clinical Genetics, University of Helsinki, and HUSLAB, Helsinki University Hospital, Helsinki, Finland. ^[6]

关键词 CHEK2 breast cancer double heterozygote moderate-risk gene ovarian cancer